Advanced Infectious Disease Epidemiology

Professor
James S. Koopman MD MPHProfessor
Steven Meshnick MD PhDTuesdays, Thursdays 1:30-3:00 P.M. Rm 3040 SPH I
INSTRUCTORS
|
|
Steve Meshnick |
Jim Koopman |
|
Office |
2039a SPH I |
3043 SPH I |
|
Phone/e-mail |
7-2406, meshnick@umich.edu |
3-5629, jkoopman@umich.edu |
|
Office hours |
Tuesdays 3-5 |
Tuesdays and Thursday mornings 11-12 |
COURSE DESCRIPTION
This second course in epidemiology will further prepare students to practice infectious disease epidemiology in both developed and developing countries in health departments, NGOs, and academic settings. It addresses the mechanisms and social factors which make infectious disease epidemiology differ from non-infectious disease epidemiology with regard to risk assessment and control program implementation. Focus will be on how risk factors, contact patterns, transmission dynamics, and pathogen evolution determine endemic and epidemic levels of infection. Students will be given an understanding of traits shared by all infectious agents (such as virulence) as well as those that are disease-specific. Students will get practice in presenting an integrative infectious disease analysis approach to a problem of their choosing.
COURSE OBJECTIVES
COMPETENCIES
READINGS
Required readings will either be on the Web or on reserve in the SPH library.
GRADING
Midterm 30%
Presentation 30%
Final 40%
CLASS PRESENTATIONS
The presentations should include:
|
Descriptive epidemiology |
Geographical distribution, risk factors, impact, surveillance and control |
|
Biological issues |
Natural history of infection, pathogen factors (virulence, diversity), host factors (immunity, genetics), infection detection methods |
|
Transmission systems |
Mode of transmission, R(o) estimates, important variables in the transmission system and how they affect dynamics, effect of asymptomatic infections and carriers, how different the transmission system is between developed and developing countries and how that might affect control. |
|
Open questions |
What else needs to be known/investigated? |
SYLLABUS
|
Date |
Instructor |
Lecture Title |
Topics |
|
9/9 |
Meshnick |
History and Overview |
Infectious diseases and history Changing paradigms of disease |
|
9/14 |
Koopman |
Microbes and humanity. |
How many and what varieties of microbes depend upon us in their competition with other microbes? How important is learning about these to human health? How important is the transmission system circulating these among humans to human health? Readings for Koopman lectures through 9/28 are available on the web or will be handed out. Lecture overheads for the 9-14 lecture are on the web. |
|
9/16 |
Meshnick |
Host response to infection |
Introduction to immunology Genetics of susceptibility |
|
9/21 |
Koopman |
Transmission systems |
The elements of transmission systems Continuous model approaches to transmission system analysis Discrete transmission system models Lecture notes for this and the next lecture are on the web. |
|
9/23 |
Meshnick |
Biological characteristics of infectious agents and their implications for transmission, disease and control |
Evolution of virulence Lifecycles, reservoirs and routes of transmission Micro- vs. Macro-parasites |
|
9/28 |
Koopman |
Assessing Individual and Population Effects of Risk Factors For Transmission |
How simple models help conceptualize the task of risk factor assessment |
|
9/30 |
Meshnick |
Vaccines and drugs for infectious disease |
Types of vaccines and practical issues Antibiotics & antiparasitics; Evolution of drug resistance Single vs multiple drug therapy |
|
10/5 |
Koopman |
Analysis of Infectious Disease Problems and Data |
The dimensions of infectious disease data and the use of transmission system models to integrate the analysis of data Estimating transmission system parameters and R0 |
|
10/7 |
Meshnick |
Water- and food-borne infections |
Cholera Bacterial vs. Protozoal |
|
10/12 |
Koopman |
Modeling and Analyzing Vaccine and Drug Effects |
Direct effects on susceptibility, course of infection, and contagiousness. All or none and partial susceptibility effects Indirect effects of vaccines How to interpret vaccine effect estimates |
|
10/14 |
|
MIDTERM |
|
|
10/19 |
Meshnick |
Malaria |
Epidemiological patterns Interventions |
|
10/21 |
Koopman |
Microbial Risk Assessment for Water-borne pathogens |
Determining the role of risk factors or modes of transmission in the transmission system. Dose Response Aspects of Risk Assessment |
|
10/26 |
Meshnick |
AIDS |
Differences between rich and poor countries |
|
10/28 |
Koopman |
HIV/STD transmission systems |
What determines the rate of epidemic rise and the endemic levels reached? What are the basic differences between heterosexual, IDU, and homosexual transmission systems? What aspects of contact patterns are crucial in determining population levels of infection? How can treatment and vaccination affect the transmission system? |
|
11/2 |
Meshnick |
Mycobacterial diseases |
TB pathogenesis: history; changes in transmission patterns, Leprosy, Control strategies |
|
11/4 |
Koopman |
Studying HIV/STD transmission systems and risk factors |
Why and how individual level studies need to take transmission system models into account Why and how transmission system studies depend upon individual level studies |
|
11/9 |
Meshnick |
Helminths |
Hookworm (history and current unknowns) Guinea Worm Eradication Program Schistosomiasis. Onchocerciasis (OCP and APOC) |
|
11/11 |
Koopman |
Surveillance Systems For Transmission System Control And Detection of Emerging Infections |
|
|
11/16 |
Koopman |
Human microbial evolution and transmission systems |
Using DNA Sequence Data To Describe Transmission Systems Do organisms continually evolve to increase their R0? If so, how does that affect our health? Why do some infectious disease problems emerge and disappear like Staph phage type 50 or rheumatic fever? How do changing contact patterns and antibiotic use affect microbe evolution? |
|
11/18 |
Students |
|
|
|
11/23 |
Students |
|
|
|
11/30 |
Carl Simon |
Influenza Transmission Systems and Evolution |
|
|
12/3 Friday |
Meshnick |
Prions |
What is the agent of BSE? Epidemiology and interventions |
|
12/7 |
Students |
|
|
|
12/9 |
Students |
|
|